Literature DB >> 10077173

Lack of association between hepatitis C infection and development of AIDS-related lymphoma.

A M Levine1, R Nelson, E Zuckerman, T Zuckerman, S Govindarajan, B Valinluck, L Bernstein.   

Abstract

Hepatitis C virus (HCV) has been associated with various lymphoproliferative disorders, and a high prevalence (9%-32%) of chronic HCV infection has been demonstrated among patients with lymphoma. Dual coinfection by HIV and HCV has been demonstrated in approximately 40% of certain populations of HIV-infected individuals. Because of this high prevalence of coinfection by HIV and HCV, the known relations between HCV and lymphoproliferative disorders, and the association of HIV and B cell lymphoma, the potential association between chronic HCV and the development of AIDS-related lymphoma was examined. The prevalence of HCV infection in HIV-infected patients with lymphoma was compared with that in patients with AIDS, diagnosed on the basis of an illness other than lymphoma. Risk factors for HCV infection, overall, were also evaluated. Evidence of HCV infection was ascertained by assessing anti-HCV antibodies, and HCV RNA in serum. The study consisted of 99 homosexual/bisexual men with AIDS-related lymphoma, and 43 other AIDS patients. HCV infection was detected in 11 of 99 (11.1 %) men with lymphoma, and in 5 of 43 (11.6%) other AIDS patients. Further, in patients with AIDS-related lymphoma, no relation was found between HCV infection and lymphoma histology or site. History of use of injected illicit drugs was associated with a significantly elevated risk of HCV infection in the combined group of lymphoma and other AIDS patients. The current study demonstrates no relation between dual infection by HIV and HCV and subsequent increased risk of lymphoma.

Entities:  

Mesh:

Year:  1999        PMID: 10077173     DOI: 10.1097/00042560-199903010-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  7 in total

1.  Moving forward in HIV-associated cancer.

Authors:  Satish Gopal; Chad J Achenbach; Elizabeth L Yanik; Dirk P Dittmer; Joseph J Eron; Eric A Engels
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

2.  Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study.

Authors:  Todd M Gibson; Lindsay M Morton; Meredith S Shiels; Christina A Clarke; Eric A Engels
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

3.  Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients.

Authors:  Lindsay M Morton; Ola Landgren; Nilanjan Chatterjee; David Castenson; Ruth Parsons; Robert N Hoover; Eric A Engels
Journal:  Blood       Date:  2007-09-12       Impact factor: 22.113

Review 4.  Hepatitis c and lymphoma.

Authors:  F Silvestri; A Sperotto; R Fanin
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

5.  A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal.

Authors:  Corry van den Bosch
Journal:  Adv Hematol       Date:  2011-11-29

6.  Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study.

Authors:  S Franceschi; J Polesel; M Rickenbach; L Dal Maso; N M Probst-Hensch; C Fux; M Cavassini; B Hasse; A Kofler; B Ledergerber; P Erb; G M Clifford
Journal:  Br J Cancer       Date:  2006-11-14       Impact factor: 7.640

7.  Virus-associated lymphomagenesis.

Authors:  V Z Tarantul
Journal:  Int J Biomed Sci       Date:  2006-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.